The company was founded in 1949 by Earl Bakken and Palmer Hermundslie. With a turnover of 16 billion U.S. dollars in 2012 was a gain of $ 3.6 billion will be generated. In the same period, around 45,000 people were employed by Medtronic.
Particularly well known is the company for their pacemakers, implantable cardioverter defibrillators, heart valves, insulin pumps, Aortenstentgrafts, coronary and neuro-stimulators. From Medtronic more than half of the world's implanted cardiac pacemakers are made .
The market capitalization of Medtronic Inc. is currently (May 7, 2013) at 36.9 billion euros.
The Medtronic GmbH in Germany has its headquarters in sea Busch since 1970. End of 2008, the new Germany headquarters was based there. Currently working there about 240 of the approximately 800 German employees. For the future, Medtronic plans to expand further into the sea bush.
The Medtronic GmbH in Austria has its headquarters in Vienna. The European headquarters of Medtronic 's Tolochenaz (VD ), Switzerland, settled. In Europe, about 6,000 employees currently work.
The end of 2007 it was announced that the electrodes of the series "Sprint Fidelis " can break under certain circumstances and are associated with five deaths in the U.S., Medtronic paid in 2010 to 3700 plaintiff 268 million USD.
On July 12, 2013 entered a preliminary injunction in place that prohibits the sale of transcatheter aortic valve implantation system ( TAVI ) CoreValveR and CoreValveR EvolutTM in Germany. However, the cause is not a technical defect, but the violation of the Edwards - Spenser patent. Therefore, the intra- existing clinically TAVI systems may continue to be implanted.